MedTrace Logo

Search for Fragility Indicators Among People Aged 50+ With Chronic HIV Infection

NCT02874118 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 510

Last updated 2023-04-07

No results posted yet for this study

Summary

The frailty and frail elderly was defined in 2001 by Fried as a physiological state of heightened vulnerability to external shocks. 5 criteria for classifying the elderly in 3 categories: frail, pre-frail and not frail. The prevalence of frailty in the general population was estimated to be 7%, 10% and 20% for over 65 years and 45% for over 85 years. This concept is explored in some chronic diseases, in order to prevent the loss of autonomy and tailor the treatment. In the carrier population of HIV, a North American retrospective study showed the frailty syndrome manifested as early as 10 years before, than in the general population. Furthermore various studies show in this specific population, increased incidence of diseases linked to age, suggesting an accelerated and premature aging.

objectives: The objective of this study is to determine the prevalence of frailty defined Fried syndrome in a population of subjects aged 50 and over Holders of chronic HIV infection.

Conditions

  • Frail in HIV Population

Interventions

BEHAVIORAL

Fried scale for frailty assessement

Sponsors & Collaborators

  • Assistance Publique Hopitaux De Marseille

    lead OTHER

Principal Investigators

  • Ureielle DESALBRES · Assistance Publique Hôpitaux de Marseille

  • Nathalie PETIT, MD · Assistance Publique Hôpitaux de Marseille

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-26
Primary Completion
2014-06-10
Completion
2023-04-06

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02874118 on ClinicalTrials.gov